Clinical Lung Cancer impact factor, indexing, ranking (2024)

Aim and Scope

The Clinical Lung Cancer is a research journal that publishes research related to Biochemistry, Genetics and Molecular Biology; Medicine. This journal is published by the Elsevier. The ISSN of this journal is 19380690, 15257304. Based on the Scopus data, the SCImago Journal Rank (SJR) of clinical lung cancer is 1.137.

Also, please check the following important details about clinical lung cancer: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Clinical Lung Cancer Ranking

The Impact Factor of Clinical Lung Cancer is 4.84.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

clinical lung cancer Indexing

The clinical lung cancer is indexed in:

• UGC CARE
• Scopus
• Web of Science (SCIE)
• PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Clinical Lung Cancer Impact Factor 2024

The latest impact factor of clinical lung cancer is 4.84.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.

Clinical Lung Cancer Quartile

The latest Quartile of clinical lung cancer is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Clinical Lung Cancer?

If your research is related to Biochemistry, Genetics and Molecular Biology; Medicine, then visit the official website of clinical lung cancer and send your manuscript.

Tips for publishing in Clinical Lung Cancer:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.

Final Summary